C Ray Therapeutics raises $100 million to develop radiopharmaceuticals
By Clara Rodriguez Fernandez
News & Analysis on Clinical Trial Services & Contract Research And Development
Trends
Bioavailbility challenge
More→
Promotional features
More→
Streamlining early phase drug development with continuous flow technologies
Paid for and in partnership with Lonza Small Molecules
Achieving data integrity: Best practices for secure and reliable data management
Paid for and content provided by METTLER TOLEDO
AI transforms route scouting for faster drug synthesis
Paid for and in partnership with Lonza Small Molecules
Decentralized clinical trials: The trends, the market and the future
Paid for and content provided by DHL Supply Chain
Clinical evolution
More→
Globalization
More→
Patient centricity
More→
Pfizer’s HYMPAVZI for Hemophilia A or B receives EU approval
By Larissa Warneck-Silvestrin
Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease
By Larissa Warneck-Silvestrin
Tirzepatide prevents type 2 diabetes in 99% of prediabetic patients for 3 years
By Clara Rodriguez Fernandez
Transparency on trial
More→
